Navigation Links
Most Read Pharmaceutical and Health News - March '13
Date:4/23/2013

AUSTIN, Texas, April 23, 2013 /PRNewswire/ -- dailyRx News Network announced today the most popular health topics viewed and shared during March 2013. dailyRx News publishes and syndicates consumer-centric health information across YouTube, mobile apps, various news aggregators, as well as through a national network of healthcare providers' social media channels.

"As the digital age evolves, a growing number of adults are using their smartphones and tablets to research health news and information," said Donald W. Hackett , CEO and Publisher of dailyRx News. "It is important that on-the-go eHealth consumers have access to a trusted digital health news resource at their fingertips," Hackett added.

According to Pew Research Center's Project for Excellence in Journalism, digital news consumption was up to 50% in 2012, increasing from 44% in 2010. In addition, a study by InSite Consulting found that 42% of people turn to TV as their primary and initial device in breaking news situations, with 66% then using the Internet to further investigate stories.

Health conditions generating notable viewer engagement on dailyRx.com last month included:

March's most-viewed medications included:

Trending health news throughout dailyRx social media included:

About dailyRx News Network
dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for accuracy by doctors, pharmacists, and therapists. dailyRx, Inc. is a Patient Conversation Media company.


'/>"/>
SOURCE dailyRx News Network
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. European Nuclear Medicine / Radiopharmaceuticals Market - Global Trends & Forecasts to 2017
2. Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
3. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
4. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
5. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
6. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
7. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
8. Comparison of Biopharmaceutical Industry Between China and India 2013
9. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
10. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
11. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):